Zheng Xing Xing Ye Ri Bao·2025-11-04 08:45Core Insights - The medical device sector experienced a decline of 1.36% on November 4, with Danaher Biomedical leading the drop [1][2] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] Medical Device Sector Performance - Notable gainers included: - Weigao Blood Purification (603014) with a closing price of 46.53, up 10.00% and a trading volume of 157,800 shares, totaling 727 million yuan [1] - Micron Technology (300341) closed at 18.88, up 7.27% with a trading volume of 282,100 shares, totaling 521 million yuan [1] - ZhenDe Medical (603301) closed at 94.69, up 5.60% with a trading volume of 233,600 shares, totaling 2.158 billion yuan [1] - Major decliners included: - Danaher Biomedical (60000ZG6) closed at 85.00, down 16.75% with a trading volume of 44,100 shares [2] - Hotgen Biotech (688068) closed at 140.65, down 10.24% with a trading volume of 51,900 shares, totaling 753 million yuan [2] - Tianzhihang (688277) closed at 17.42, down 6.60% with a trading volume of 139,000 shares [2] Capital Flow Analysis - The medical device sector saw a net outflow of 792 million yuan from institutional investors, while retail investors contributed a net inflow of 401 million yuan [2][3] - Key stocks with significant capital flow include: - Weigao Blood Purification (603014) had a net inflow of 111.4 million yuan from institutional investors, but a net outflow of 82.5 million yuan from retail investors [3] - Micron Technology (300341) experienced a net inflow of 55.9 million yuan from institutional investors, with a net outflow of 19.0 million yuan from retail investors [3] - ZhenDe Medical (603301) had a net inflow of 33.2 million yuan from institutional investors, but a net outflow of 53.4 million yuan from retail investors [3]